Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|November 19, 2018
- Dermatology Times, November 2018 (Vol. 39, No. 11)
- Volume 39
- Issue 11
A guide to wound care
Author(s)Dermatology Times Staff
Advertisement
In this table, we cover the basics of wound care, such as reducing bioburden, reducing edema and maintaining a moist wound environment. This information was gathered from a 2014 article from the journal, Plastic Surgical Nursing, in which Marcia Spear, DNP, ACNP-BC, CWS, CPSN, addressed the “Principles of Wound Care - Back to Basics.”
(Click here for a
)
Articles in this issue
almost 8 years ago
Low-dose bleomycin injections result in curious side effectalmost 8 years ago
7 Safety recommendations for tattoo removalalmost 8 years ago
Being older helps skin heal with less scarringalmost 8 years ago
Topical sirolimus shows positive results in two studiesalmost 8 years ago
Wound healing in psoriasis, multiple sclerosisalmost 8 years ago
Classifying diabetic foot ulcersalmost 8 years ago
Role of protease targets in wound healing uncertainalmost 8 years ago
Allograft Tissue Research Grant program taking applicantsalmost 8 years ago
Verrica develops a solution for common wartsalmost 8 years ago
Sarecycline approved for moderate-to-severe acneAdvertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Tina Bhutani-Jacques, MD, explored how disease location, prior treatment response, and patient preference shape topical treatment decisions across 3 plaque psoriasis cases.
Benjamin Ungar, MD, moderated a recent Dermatology Times Case-Based Roundtable event on how to define severity, choose among JAK inhibitors, and monitor patients with alopecia areata.
Clinicians at a Dermatology Times Case-Based Roundtable, moderated by Chesahna Kindred, MD, debated when to escalate to oral JAK inhibitors for alopecia areata and how to counsel patients on timing, monitoring, and safety.
The joint AAD-HSF guideline issues 37 recommendations, including strong support for adalimumab, bimekizumab, infliximab, and secukinumab.
Two-year oral IL-23 data, GLP-1 biomarker findings, and a nonsurgical option for superficial basal cell carcinoma headline the sessions covered in Las Vegas.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Skin Longevity Needs Evidence, Not Hype
4
Individualizing Systemic Therapy for Alopecia Areata Across Patient Cases
5